JABLI Trademark

Trademark Overview

On Tuesday, May 27, 2008, a trademark application was filed for JABLI with the United States Patent and Trademark Office. The USPTO has given the JABLI trademark a serial number of 77483487. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 23, 2012. This trademark is owned by Glaxo Group Limited. The JABLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
jabli

General Information

Serial Number77483487
Word MarkJABLI
Filing DateTuesday, May 27, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 23, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "JABLI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 30, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, July 23, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2012EXTENSION 5 GRANTED
Thursday, December 15, 2011EXTENSION 5 FILED
Thursday, December 15, 2011TEAS EXTENSION RECEIVED
Wednesday, December 14, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2011EXTENSION 4 GRANTED
Tuesday, June 14, 2011EXTENSION 4 FILED
Tuesday, June 14, 2011TEAS EXTENSION RECEIVED
Wednesday, November 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2010EXTENSION 3 GRANTED
Thursday, October 28, 2010EXTENSION 3 FILED
Thursday, October 28, 2010TEAS EXTENSION RECEIVED
Wednesday, June 30, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 29, 2010EXTENSION 2 GRANTED
Thursday, June 3, 2010EXTENSION 2 FILED
Tuesday, June 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 3, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 25, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 3, 2009EXTENSION 1 GRANTED
Thursday, December 3, 2009EXTENSION 1 FILED
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Tuesday, June 23, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Thursday, February 26, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 24, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 12, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 12, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 12, 2009ASSIGNED TO LIE
Wednesday, February 11, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 27, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2008NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2008NON-FINAL ACTION WRITTEN
Wednesday, August 27, 2008ASSIGNED TO EXAMINER
Friday, May 30, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

jabli pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic